Statements (100)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:virus
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Contagion
|
| gptkbp:advises |
for outbreak response
|
| gptkbp:affects |
mental health issues
economic impact on communities |
| gptkbp:casualties |
can transmit virus through bodily fluids
may have long-term health issues |
| gptkbp:caused_by |
Ebola virus disease
hemorrhagic fever |
| gptkbp:clinical_trial |
conducted in affected regions
|
| gptkbp:collaborations |
necessary for response
|
| gptkbp:community_engagement |
critical for outbreak control
essential for control efforts |
| gptkbp:complications |
vision problems
joint pain neurological issues |
| gptkbp:contact |
animals can transmit
|
| gptkbp:cultural_practices |
impact transmission rates
|
| gptkbp:debut_year |
gptkb:1976
|
| gptkbp:discovered_by |
gptkb:Zaire
gptkb:Peter_Piot Jean-Jacques Muyembe |
| gptkbp:end_of_life |
up to 90%
up to 90% in some outbreaks |
| gptkbp:family |
gptkb:Filoviridae
|
| gptkbp:first_introduced |
Yambuku
|
| gptkbp:genus |
gptkb:Ebolavirus
|
| gptkbp:healthcare |
gptkb:significant
concern important concern |
| https://www.w3.org/2000/01/rdf-schema#label |
Ebola
|
| gptkbp:incubation_period |
symptoms appear
|
| gptkbp:involved_countries |
gptkb:Sierra_Leone
gptkb:Politician gptkb:Sudan gptkb:Democratic_Republic_of_the_Congo gptkb:Liberia gptkb:dog_breed |
| gptkbp:is_monitored_by |
important for early detection
improved after outbreaks |
| gptkbp:is_protected_by |
quarantine
personal protective equipment healthcare worker training safe burial practices avoid contact with infected individuals |
| gptkbp:is_recognized_by |
gptkb:1976
|
| gptkbp:is_vulnerable_to |
gptkb:r_VSV-ZEBOV
over 90% in trials high in clinical trials critical during outbreaks developed by Merck |
| gptkbp:media_coverage |
increases during outbreaks
|
| gptkbp:named_after |
Ebola River
|
| gptkbp:native_to |
gptkb:Africa
|
| gptkbp:notable_event |
2014-2016 West Africa outbreak
|
| gptkbp:nutritional_value |
gptkb:Filoviridae
|
| gptkbp:public_awareness |
critical for prevention
essential for prevention. |
| gptkbp:receives_funding_from |
increased after outbreaks
increased post-outbreaks |
| gptkbp:research |
treatment protocols
ongoing for treatments ongoing vaccine development |
| gptkbp:research_areas |
gptkb:CDC
gptkb:NIH gptkb:WHO |
| gptkbp:reservoir |
fruit bats
non-human primates |
| gptkbp:responds_to |
gptkb:railway_line
international aid mobilization requires coordination among nations |
| gptkbp:social_responsibility |
gptkb:2021_outbreak_in_Guinea
gptkb:Marburg_virus gptkb:Reston_virus serological tests PCR test serology tests 2014-2016 West Africa outbreak 2018-2020 outbreak in DRC 2022 outbreak in DRC frequent in Central Africa frequent in West Africa frequent in Africa |
| gptkbp:symptoms |
headache
muscle pain fever sore throat vomiting diarrhea rash stomach pain internal bleeding unexplained bleeding |
| gptkbp:transmission |
bodily fluids
direct contact with bodily fluids |
| gptkbp:treatment |
supportive care
monoclonal antibodies antiviral drugs experimental vaccines |